| Metric | Oct 25, 2024 FY24 Q3 | Jan 31, 2025 FY24 Q4 | Apr 25, 2025 FY25 Q1 | Jul 25, 2025 FY25 Q2 | Oct 24, 2025 FY25 Q3 | Jan 30, 2026 FY25 Q4 | Apr 24, 2026 FY26 Q1 | Jul 24, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2027 | ||||||||
| Calendar-year 2027 revenue | — | — | — | — | — | — | New“$2.80 billion and $2.90 billion” | Reiterated“$2.80 and $2.90 billion” |
| Revenue | — | — | — | — | — | New“between $2.75 and $2.85 billion” | Raised“between $2.80 billion and $2.90 billion” | Reiterated“$2.80 and $2.90 billion” |
| For FY2026 | ||||||||
| Calendar year 2026 revenue | — | New“between $2.55 and $2.65 billion” | — | — | — | — | — | — |
| Consolidated Revenue | — | — | — | — | — | — | New“$2.65 – $2.75 billion” | Reiterated“$2.65 – $2.75 billion” |
| Revenue | — | New“between $2.55 and $2.65 billion” | — | — | — | Raised“$2.60 - $2.70 Billion” | — | — |
| Gross Margin | — | — | — | — | — | New“34% - 35%” | Reiterated“34% – 35%” | Raised“34.5% – 35.5% (previously 34% - 35%)” |
| Capital Expenditures | — | — | — | — | — | New“$125 - $140 million” | Reiterated“$125 – $140 million” | Lowered“$115 – $125 million (previously $125 - $140 million)” |
| Depreciation & Amortization | — | — | — | — | — | New“$100 - $110 million” | Reiterated“$100 – $110 million” | Reiterated“$100 – $110 million” |
| Estimated Annual Tax Rate | — | — | — | — | — | New“16% - 18%” | — | — |
| Operating Expenses (E,R&D and S,G&A) | — | — | — | — | — | New“$410 - $420 million” | — | — |
| Tax Rate | — | — | — | — | — | — | New“16% – 18%” | Narrowed“16% – 17% (previously 16% -18%)” |
| For FY2025 | ||||||||
| Calendar year 2025 revenue estimates | New“approximately $2.45 - $2.55 billion” | — | — | — | — | — | — | — |
| Consolidated Revenue | — | — | — | New“$2.44 – $2.61 billion” | Narrowed“$2.50 – $2.60 billion” | — | — | — |
| Consolidated Revenue - Gentex China market | — | — | — | New“$100 – $125 million” | Raised“$135 – $145 million” | — | — | — |
| Consolidated Revenue - Gentex primary markets | — | — | — | New“$2.10 – $2.20 billion” | Narrowed“$2.14 – $2.15 billion” | — | — | — |
| Consolidated Revenue - VOXX Revenue estimate | — | — | — | New“$240 – $280 million” | Narrowed“$250 – $275 million” | — | — | — |
| Expected revenue contribution from the merger | — | — | New“approximately $240 to $280 million” | — | — | — | — | — |
| Revenue | New“approximately $2.45 - $2.55 billion” | Lowered“$2.40 - $2.45 Billion” | — | — | — | — | — | — |
| Revenue - China | — | — | New“$50 - $120 million” | — | — | — | — | — |
| Revenue - Primary Markets | — | — | New“$2.40 - $2.45 billion” | — | — | — | — | — |
| Revenue Outgrowth versus Primary Markets | — | New“a 7% outgrowth versus our primary markets” | — | — | — | — | — | — |
| VOXX Merger Revenue Contribution | — | — | New“approximately $240 to $280 million” | — | — | — | — | — |
| Gross Margin | — | New“33.5% - 34.5%” | Reiterated“33.5% - 34.5%” | Lowered“33% – 34%” | Narrowed“33.5% – 34%” | — | — | — |
| Gross Margin - Gentex (stand-alone) | — | — | — | New“34% – 34.5%” | Raised“34.25% – 34.75%” | — | — | — |
| Gross Margin - VOXX (stand-alone) | — | — | — | New“27% – 29%” | Narrowed“28% – 29%” | — | — | — |
| Target gross margin | — | New“approximately 35%” | — | — | — | — | — | — |
| Targeted gross margin | New“35 - 36%” | — | — | — | — | — | — | — |
| Capital Expenditures | — | New“$125 - $150 million” | Reiterated“$125 - $150 million” | Lowered“$100 – $125 million” | Narrowed“$115 – $125 million” | — | — | — |
| Depreciation & Amortization | — | New“$85 - $90 million” | Reiterated“$85 - $90 million” | Raised“$91 – $98 million” | Raised“$96 – $99 million” | — | — | — |
| Depreciation & Amortization - Gentex | — | — | — | New“$90 – $95 million” | Raised“$95 – $96 million” | — | — | — |
| Depreciation & Amortization - VOXX | — | — | — | New“$1 - $3 million” | Reiterated“$1 - $3 million” | — | — | — |
| Estimated Annual Tax Rate | — | New“15% - 17%” | — | — | — | — | — | — |
| Operating Expenses - Gentex | — | — | — | New“$300 – $310 million” | Narrowed“$305 – $310 million” | — | — | — |
| Operating Expenses - VOXX | — | — | — | New“$70 – $80 million” | Narrowed“$75 – $80 million” | — | — | — |
| Operating Expenses (E,R&D and S,G&A) | — | New“$310 - $320 million” | — | — | — | — | — | — |
| Operating Expenses (excluding severance) | — | — | New“$310 - $320 million” | Raised“$370 – $390 million” | Narrowed“$380 – $390 million” | — | — | — |
| Tax Rate | — | — | New“15% - 17%” | Narrowed“16% – 17%” | Narrowed“16% – 16.5%” | — | — | — |
| For FY2024 | ||||||||
| Revenue | New“$2.40 - $2.50 billion” | — | — | — | — | — | — | — |
| Gross Margin | New“33.5% - 34.0%” | — | — | — | — | — | — | — |
| Capital Expenditures | New“$175 - $200 million” | — | — | — | — | — | — | — |
| Depreciation & Amortization | New“$95 - $100 million” | — | — | — | — | — | — | — |
| Operating Expenses | New“$295 -$305 million” | — | — | — | — | — | — | — |
| Tax Rate | New“15% - 15.5%” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Revenue from the merger, on an annualized basis | — | — | New“between $325 and $375 million” | — | — | — | — | — |
| VOXX Merger Annualized Revenue Contribution | — | — | New“between $325 and $375 million” | — | — | — | — | — |
| Core margin profile / long-term target | — | — | — | New“35 - 36%” | — | — | — | — |
| Gross Margin | New“35 - 36%” | — | — | — | — | — | — | — |
| Cost Improvement Initiatives (Positive Cash Flow) | — | — | — | — | — | New“approximately $40 million per year” | — | — |